Stock Update: AbbVie Inc (NYSE:ABBV) – AbbVie Announces Expiration of Hart-Scott-Rodino Waiting Period for AbbVie’s Acquisition of Pharmacyclics

[PR Newswire] – The expiration satisfies the exchange offer condition with respect to the approvals and clearances required under antitrust laws. Assuming that the other customary exchange offer conditions are satisfied, including a . . . → Read More: Stock Update: AbbVie Inc (NYSE:ABBV) – AbbVie Announces Expiration of Hart-Scott-Rodino Waiting Period for AbbVie’s Acquisition of Pharmacyclics Similar Articles: Company Update (NYSE:ABBV): AbbVie Extends Exchange Offer to Acquire Pharmacyclics, Inc. Market Update: AbbVie Inc (NYSE:ABBV) – AbbVie Extends Exchange Offer to Acquire Pharmacyclics, Inc. Company Update (NYSE:BSX): Boston Scientific announces FDA and CE Mark Approval Of The EMBLEM™ S-ICD System